Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

September 26, 2018
Policy News
Kelvyn H. Cullimore Jr Appointed as President & CEO of BioUtah

SALT LAKE CITY, UT (September 28, 2018) – BioUtah today announced that the board of directors has selected Kelvyn H. Cullimore Jr. as its president and CEO. Cullimore will succeed Kelly Slone, who has served in that capacity for the past three years.   Cullimore comes to BioUtah with deep experience in both industry and […]

September 14, 2018
Policy News
BioUtah Announces Jeffrey Shuren, MD, JD, Director of the Center for Devices and Radiological Health as the Luncheon Keynote Speaker for the 9th Annual Utah Life Sciences Summit

Dr. Shuren will take the stage as the luncheon keynote at the 2018 BioUtah Utah Life Sciences Summit, speaking to the state’s premier gathering of industry leaders, innovators, government officials, educators, and investors September 14, 2018 10:00 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah, Utah’s only trade association dedicated solely to the life sciences community, […]

September 5, 2018
Policy News
BioUtah Announces Registration and Headline Speakers for the 9th Annual Utah Life Sciences Summit (ULSS)

Registration opens today for the 2018 BioUtah ULSS, offering early bird discounts. Preliminary speaker line-up includes notable business leaders, policy makers and members of the investor community Salt Lake City, UT – September 5, 2018 – BioUtah, Utah’s one and only association dedicated to the life sciences community, today announced that registration is open for […]

August 31, 2018
Policy News
ULSS Early Bird Registration Opens September 5th

On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the premier conference for companies on the cutting edge of medical innovation, and provides a unique opportunity to connect with national leaders in the life sciences industry. Please join us for keynote speakers, panels, and networking opportunites that […]

August 28, 2018
Policy News
U OF U’S KEM C. GARDNER POLICY INSTITUTE RELEASES NEW STUDY ON UTAH LIFE SCIENCES INDUSTRY

BioUtah is pleased to share with you the newly released study by the Kem C. Gardner Policy Institute on the impact of Utah’s life sciences industry on the state’s economy. The study, the “Economic Impacts of Utah’s Life Sciences Industry” can be viewed in full here. The Gardner Policy Institute announced the study’s findings this […]

August 14, 2018
Policy News
Mountain Pacific Venture Fund secures LP commitment from TY BIO Investment

Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has closed the first institutional investment into its debut fund, which invests in and supports innovative life science and biotech companies. The investment into Mountain Pacific Venture Fund was made by TY BIO Investment, Inc., a wholly-owned subsidiary […]

July 25, 2018
Policy News
BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax

FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]

June 18, 2018
Policy News
RARE on the Road in Salt Lake City, UT

Please join us and Global Genes on Saturday, June 30th for RARE on the Road Rare Disease Leadership Tour in Salt Lake City, Utah. This conference will educate rare disease patients, caregivers and other advocates through collaboration in an interactive and engaging environment.

June 11, 2018
Policy News
Biomerics Acquires FutureMatrix Interventional

Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets.

May 30, 2018
Policy News
Reimbursement Trends Webinar

Joins us for a timely update from Brian Carey, Partner, Foley Hoag, on reimbursement trends for precision medicine and Kim Linthicum, Vice President of Government Affairs, Myriad, on proposed legislation that would create a new regulatory pathway for diagnostics.

May 17, 2018
Policy News
The MedTech Conference 2018

The MedTech Conference will take place on September 24th – 26th 2018 at the Pennsylvania Convention Center in Philadelphia.

May 9, 2018
Policy News
New Seed Fund to Advance Commercialization at University of Utah

The Center for Technology & Venture Commercialization at the University of Utah announced a new funding program for early stage technology development and commercialization.

April 30, 2018
Life Sciences Industry News
DiscGenics Company Update

We officially commenced clinical evaluation of IDCT for degenerative disc disease last month, and just yesterday, announced the first patient has been treated in our U.S. Phase I/II trial.

April 30, 2018
Life Sciences Industry News
BioUtah Applauds Utah’s Life Sciences Award Winners and Finalists

SALT LAKE CITY–(BUSINESS WIRE)–Utah life sciences companies, and BioUtah members, ProLung, Inc., and Rosivo Inc., were among ten innovative companies announced as winners in the 16th annual Utah Innovation Awards, presented by Stoel Rives, LLP, and the Utah Technology Council. Winners were honored during a special awards dinner, April 26, at the Hilton Salt Lake […]

April 30, 2018
Life Sciences Industry News
Biomerics and ATL Technologies Acquire CRI Medical

Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions.

April 29, 2018
Life Sciences Industry News
Tolero Pharmaceuticals in the Daily Herald

On April 22, the Daily Herald published an article highlighting Tolero Pharmaceuticals’ research in “personalized medicine.” This concept is based on the idea that drugs can be more effective once doctors know whether or not they will be right for specific patients. “It’s the right drug for the right patient for the right disease,” said Kelly Slone, president […]

April 23, 2018
Life Sciences Industry News
Senator Orrin Hatch Honored for Biotech Advocacy

Jim Greenwood, CEO of BIO, acknowledges Senator Hatch for his groundbreaking work in biotechnology policy following his honors at BIO’s 25 Years of Innovation this month.